Purified Cortrophin Gel® (repository corticotropin injection)

Purified Cortrophin Gel is not recommended for approval/coverage—although FDA‑approved indications are listed (rheumatic, collagen, dermatologic, allergic, ophthalmic, respiratory, edematous, and nervous system disorders), current evidence is insufficient and there are potential long‑term safety concerns. If requested, the patient must have one of the FDA‑approved diagnoses and meet specific coverage criteria, but approval is still discouraged given the lack of demonstrated benefit over other therapies.

"Rheumatic disorders"

Sign up to see full coverage criteria, indications, and limitations.